Literature DB >> 31476913

Epigenetic Modulation in the Initiation and Progression of Pulmonary Hypertension.

Xinyu Cheng1, Yu Wang1, Lizhong Du.   

Abstract

Pulmonary hypertension (PH) is a severe disease with multiple etiologies. In addition to genetics, recent studies have revealed the epigenetic modulation in the initiation and progression of PH. In this review, we summarize the epigenetic mechanisms in the pathogenesis of PH, specifically, DNA methylation, histone modifications, and microRNAs. We further emphasize the diagnostic and therapeutic potential of these epigenetic hallmarks in PH. Finally, we highlight the developmental reprogramming in adult-onset PH because of adverse perinatal exposures such as intrauterine growth restriction and extrauterine growth restriction. Therefore, epigenetic modifications provide promise for the therapy and prevention of PH.

Entities:  

Keywords:  DNA methylation; adult; hypertension, pulmonary; microRNAs; rats

Mesh:

Substances:

Year:  2019        PMID: 31476913     DOI: 10.1161/HYPERTENSIONAHA.119.13458

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Stem cell therapy for pulmonary arterial hypertension: An update.

Authors:  Qiwei Wilton Sun; Zhongjie Sun
Journal:  J Heart Lung Transplant       Date:  2022-03-06       Impact factor: 13.569

2.  Bioinformatic analysis of dysregulated circular RNAs in pediatric pulmonary hypertension linked congenital heart disease.

Authors:  Danyan Su; Yanyun Huang; Dongli Liu; Yuqin Huang; Bingbing Ye; Suyuan Qin; Cheng Chen; Yusheng Pang
Journal:  Transl Pediatr       Date:  2022-05

3.  Glucose-6-phosphate dehydrogenase and MEG3 controls hypoxia-induced expression of serum response factor (SRF) and SRF-dependent genes in pulmonary smooth muscle cell.

Authors:  Atsushi Kitagawa; Christina Jacob; Sachin A Gupte
Journal:  J Smooth Muscle Res       Date:  2022

Review 4.  Current and emerging therapeutic approaches to pulmonary hypertension.

Authors:  Malik Bisserier; Natasha Pradhan; Lahouaria Hadri
Journal:  Rev Cardiovasc Med       Date:  2020-06-30       Impact factor: 2.930

5.  MicroRNA-146-5p Promotes Pulmonary Artery Endothelial Cell Proliferation under Hypoxic Conditions through Regulating USP3.

Authors:  Wei Zhang; Yujuan Qi; Bo Wu
Journal:  Dis Markers       Date:  2021-12-07       Impact factor: 3.434

6.  Disrupted establishment of anaerobe and facultative anaerobe balance in preterm infants with extrauterine growth restriction.

Authors:  Yi-E Huang; Xintian Shen; Dingding Yin; Shanwei Lan; Yongxue Lu; Ping Zhou; Liya Ma; Yinlan Zhang; Yuhui Sheng; Youjun Zhang; Mengna Li; Fei Hu; Jiaqi Chen; Pan Li; Emad M El-Omar; Huimin Zheng
Journal:  Front Pediatr       Date:  2022-09-06       Impact factor: 3.569

Review 7.  MiRNAs, lncRNAs, and circular RNAs as mediators in hypertension-related vascular smooth muscle cell dysfunction.

Authors:  Ji-Ru Zhang; Hai-Jian Sun
Journal:  Hypertens Res       Date:  2020-09-23       Impact factor: 3.872

8.  Plasma metabolomic profile in chronic thromboembolic pulmonary hypertension.

Authors:  Gustavo A Heresi; Jacob T Mey; John R Bartholomew; Ihab S Haddadin; Adriano R Tonelli; Raed A Dweik; John P Kirwan; Satish C Kalhan
Journal:  Pulm Circ       Date:  2020-02-04       Impact factor: 3.017

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.